Physician profile
Madison Koster
NPI 1194464941
$716.69
in general payments reported to CMS, 2019-2025
15 companies · $199 in 2025
The $199 reported for 2025 was more than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $112 · 2024: $405 · 2025: $199.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $717.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $716.69 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $142.27 | 2023-2025 | Wegovy, Rybelsus, Ozempic |
| Astrazeneca Pharmaceuticals LP | $105.59 | 2024-2025 | Airsupra, Farxiga |
| Amgen INC. | $90.75 | 2024-2025 | Evenity, Prolia, Prolia |
| Organon LLC | $70.94 | 2024 | |
| Abbvie INC. | $60.63 | 2023-2024 | |
| Novartis Pharmaceuticals Corporation | $56.22 | 2024-2025 | |
| Phathom Pharmaceuticals, INC. | $40.11 | 2024-2025 | Voquezna |
| Pfizer INC. | $27.64 | 2023 | |
| Glaxosmithkline, LLC. | $23.29 | 2025 | Trelegy Ellipta |
| Edwards Lifesciences Corporation | $21.85 | 2023 | Sapien 3 Ultra Resilia |
| Dexcom, INC. | $17.31 | 2024 | Dexcom G6 Transmitter |
| Janssen Pharmaceuticals, INC | $16.51 | 2024 | Xarelto |
| Insulet Corporation | $15.71 | 2025 | Omnipod |
| Bayer Healthcare Pharmaceuticals INC. | $14.40 | 2025 | |
| Lilly USA, LLC | $13.47 | 2024 | Mounjaro |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Madison Koster listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.